Paul Davis

[email protected]

Responsive - Making the most of the new banner ad formats

August 5, 2014

Page Layout Showing A Portrait Ad And Its Expansion Dimensions

Responsive - The Power of Landing Pages

August 5, 2014

2015 06 24 17 50 06 429 Inline

Responsive - 7 Deadly Sins of Landing Page Design

August 5, 2014

Responsive - 5 Short Videos to help you improve your eBroadcasts

August 5, 2014

Mismatched Goals

June 29, 2009

Lost in Translation...

February 5, 2008

2008 03 14 14 48 17 706

Agents of Change: The new wave of crawlers, spiders and bots

March 13, 2006

Defining your success

June 7, 2005

Defining your success

June 5, 2005

Rich Media: The power of being rich

March 30, 2005

Page 2 of 3

2260299 Philips 01 Aunt Minnie Leadgen Newsletter Banner 300x250 Static

Philips Interactive Multimedia Reporting: Where Insight Meets Impact

Radiology is no longer just about what you see, it’s about how effectively you communicate it.

David Vining Md Anderson Longitudinal Record Imr 2026

Radiologists estimate time savings with advanced radiology reports

Adobe Stock 1568461586 Fizkes

Interactive multimedia radiology reporting improves physician consults

Representative SV2A PET images comparing synaptic density in healthy and disease states. The left panel shows F-18 SynVesT-1 PET distribution volume (VT) maps of the brain and spinal cord in a naïve control mouse and a mouse with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. The right panel shows Cu-11 UCB-J PET images of the brain of a 46-year-old male healthy control (left) and 43-year-old female MS patient (right).

SNMMI: PET reveals new brain activity in multiple sclerosis

(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.

SNMMI: New PET platform guides real-time bone cancer margin assessment

SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater

By Kate Madden Yee

An increase in the use of radionuclide therapy has added burden to wastewater management systems.

June 1, 2026

SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year

F-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.

June 1, 2026

(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.

SNMMI: Novel radiotracer effectively images overactive adrenal glands

University of Michigan researchers report on first-in-human study of SOAT1-targeted nevanimibe C-11.

June 1, 2026

Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.

SNMMI: Mouaz Al-Mallah discusses cardiac PET

In this interview, Mouaz Al-Mallah, MD, discusses cardiac PET imaging, including new efforts to create more access for patients and the impact of new radiotracers.

June 1, 2026

Mouaz Al Mallah Thumb1

ASCO: Proton therapy, IMRT both work well for prostate cancer

By Erik L. Ridley

Both modalities yielded similar outcomes, according to preliminary results from a large, prospective trial.

June 1, 2026

SNMMI: Point-of-care PET system may guide interventional procedures

By Amerigo Allegretto

A portable, point-of-care PET system showed success in imaging organs and may be helpful in interventional guidance.

June 1, 2026

(a) Benchtop portable POC-PET prototype system. (b) Phantom imaging experiment setup. (c) Comparison of conventional full-data MLEM reconstruction with incremental OSEM reconstruction.

SNMMI: Brain-dedicated PET scanner cuts claustrophobia, boosts comfort

By Kate Madden Yee

The findings "support the use of brain-dedicated PET scanners as a patient-centered alternative," researchers wrote.

June 1, 2026

SNMMI: PET tracer detects CTE tau pathology in living patients

By Kate Madden Yee

Study findings suggest "a clinical role for PET in traumatic brain injury and sports- and military-related neurodegeneration."

May 31, 2026

Parametric maps obtained with SRTM2 (cerebellum grey matter as reference) for the group of healthy participants (top) and from one representative participant with suspected CTE (bottom). CTE: chronic traumatic encephalopathy.

SNMMI: SPECT/CT tracer shows promise in interstitial lung disease

Differentiating between fibrotic scarring and inflammation stages of disease is critical so that physicians can determine what treatment is best for the patient.

May 31, 2026

Sample images from each participant group: A: CT only; B: fused Tc-99m maraciclatide SPECT/CT.

SNMMI: Alpha-emitting tracer offers neuroendocrine tumor treatment option

By Kate Madden Yee

An alpha-emitting radiotracer produced remission in patients who had exhausted typical treatment options for neuroendocrine tumors.

May 31, 2026

ASCO: Should pathogenic variants be considered in breast cancer screening?

By Erik L. Ridley

Germline testing for PVs identify different subsets of high-risk women in risk-based breast cancer screening strategies.

May 31, 2026

SNMMI: PET tracer detects both cardiac Inflammation and tumor activity

CCR2 is expressed in both atherosclerotic plaques and tumors.

May 31, 2026

Combination therapy of JAK1i with anti-PD1 slows down tumor growth and reduces CCR2+ cells infiltration in atherosclerotic lesions compared to anti-PD1 alone. Representative PET images of cardio-oncology mice treated with anti-PD1 alone or in combination with JAK1i. The PET uptake was normalized by subtracting blood retention.

Page 2 of 231